TD Asset Management
MACK

TD Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

TD Asset Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3,305
Closed -$99K – 1325
2013
Q3 		$99K Buy
+3,305
New +$99K ﹤0.01% 1239